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CHAPTER I 
INTRODUCTION 
In the history of the treatment of mental illness many 
organic procedures have been utilized. Such therapeutic 
agents as blood-let.ting, emetics and purgatives and even 
surgical techniques such as castration and removal of the 
1 
clitoris flourished in the 19th century. A forward step 
in organic treatment was made by the injection of toxins, 
the so-called fever producing method. In 1917 Wagner-
Jauregg introduced malaria treatment in general paresis, the 
first successful treatment of a mental illness by organic 
methods. Other pharmacological treatments such as continuous 
sleep treatment, carbon dioxide, nitrogen and continuous 
oxygen have been utilized with limited success. 
The new era of the so-called shock treatments 
started with the almost simultaneous and independ-
ent discoveries of hypoglycemic coma treatment and 
pharmacological convulsive treatment.2 
These discoveries were followed shortly by the discovery of 
frontal leukotomies by Moniz and Lima in 19353 and the 
demonstration of electro-convulsive therapy · by Cerletti and 
1. R. W. White. The abnormal personality. New York: 
The Ronald Press Co., 1948. 
2. L. B. Kalinowsky and P. H. Hock. Shock treatment 
and other somatic procedures in psychiatry. New' Y'ork: 
Grune and Stratton, 1950, p. 2. 
3. W. Freeman. Psychosurgery. Springfield: C. c. 
Thomas, 1942. 
1. 
Bini in 1938. 4 Many of these procedures which were 
initially applied enthusiastically to all types of mental 
illness were later found to be applicable only to specific 
types of disorders. Others, such as nitrogen and continuous 
oxygen, have been found to have no value in the treatment of 
mental illness. All of these procedures were developed 
empirical l y, rather than loglcally derived, and the rationale 
for their use is still, by and large, unknown. This is 
partly due to the lack of systematic knowledge regarding the 
interaction between these procedures and behavior in the 
normal individual. 
The most recent innovation in the treatment of mental 
disorders is the use of "tranquillizing" or "ataraxic" drugs. 
Lik e many of the procedures mentioned above the usefulness of 
these drugs in psychiatric disorders was discovered empiric'-
ally. In 1950, a French surgeon, Laborit, who was experi-
menting with various phenothiazine derivatives in producing 
artificial hibernation synthesized the drug chlorpromazine-
hydrochlorides LJl0-3 dimethylamino-propyl)-2-chlorpheno-
thiazin~. Later studies by Hamon et a1. 6 and Delay and 
4. Kalinowsky and Hoch, ££• cit. 
5. F. Marti-Ibanez, A.M. Sackler, M.P. Sackler and 
R.R. Sackler. The challenge of bio- and chemotherapy in 
psychiatry. Journal of Clinical and Exterimental Psycho-
pathology and QuarterlY Review of--ps"ych a try and Neurology, 
1956, 17, pp. 15-18. 
6. J.P. Hamon, J. Paraire and J. Veluz. Comments on 
the action of 4560 R.P. in agitated manics. Annals of 
Medical Psychology, 1952, 110, pp. 331-335. 
2. 
Deniker7 demonstrated the usefulness of the drug in treating 
psychiatric disorders. It was introduced in the United Sta.tes 
in 1954 by Winkleman8 under the trade name "Thorazine" and 
has since found widespread clinical usage in the treatment of 
many types of mental illness, but particularly in the psychotic 
reactions. 
It is the purpose of this study to investigate the 
influence of chlorpromazine on a well-d~fined segment of 
behavior in normal individuals. The author's clinical obser-
vations of dramatic changes in gross motor behavior of 
psychotic patients aroused his curiosity regarding the effects 
of the drug on the psychomotor reactions of individuals who 
were not disturbed. In addition, part of the impetus for 
this study came from the keynote address by Dr. Kramer at a 
"Symposium on Chlorpromazine" at the Veterans Administration 
Hospital, Bedford, Massachusetts in March 1956. The following 
is an excerpt from his a~dress: 
Are many persons in the industrial population on 
these drugs? If so, how are their reaction times and 
learning abilities effected? Are such persons sub-
ject t o higher accident rates than persons not on 
these drugs? •••• Thus, much more information is needed 
on the biological, physiological and psychological 
effects of the tranquillizing drugs at various dosage 
levels when used to treat psychiatric disorders. 
7. J. Delay and P. Deniker. Chlorpromazine and neuro-
leptic treatments in psychiatry. Journal of Clinical and 
E~erimental Psychopathology and ~uarterly Review of 
Psychiatry and Neurology. '1956, 17, pp. 19-24. 
8. Marti-Ibanez et al., ££• cit. 
3. 
This experiment provides an answer to part of Dr. 
Kramer's question as well as providing basic data on the 
relationship between chlorpromazine and motoric behavior 
which can be integrated with future research to provide a 
basis for systemati·c theory construction. 
4. 
CHAPTER II 
REVIEW OF THE UTERATURE 
Since the intr9duction of chlorpromazine over 1400 
papers have been written describing results with the drug in 
anaesthesiology, pharmacology, obstetrics, surgery, geriat-
rics, general medicine and psychiatry. In addition a number 
of studies in neurology and psychology have been published. 
In reviewing the literature only those papers which have 
relevance to psychomotor functioning will be discussed. 
A. Psychiatric Research 
The general trend of psychiatric research has indicated 
t hat chlorpromazine has had a salu tory effect on mental ill-
ness. Most studies revealed improvement in all types of 
ment a l illness but particularly in the psychotic reactions. 
One such study, carried out by Sigwald et al.,9 described 
"beneficial results" in the use of chlorpromazine with a 
group of ambulatory psychiatric patients. Zeller, Graffa-
ginno, Cullen and Reitman10 compared the effects of chlor-
promazine, reserpine and a placebo in treating chronically 
disturbed psychotic patients. They reported 70.5 per cent 
----------------9. J. Sigw~ld, D. Bouttier and P. Nicolas-Charles. 
Ambulatory treatment with chlorpromazine. Journal of 
Clinical and Experimental Psychopathology and Quarterly 
Review of-psychiatry and Neurology, 1956,-r?, pp. 57-69. 
10. w.w. Zeller, P.N. Graffaginno, C. Cullen and 
H.J. Reitman. Use of Chlorpromazine in the treatment of 
emotional disorders. J.A. M.A., 1956, 160, pp. 179-184. 
5. 
improvement among those treated with chlorpromazine against 
20.7 per cent with placebo. Criteria for improvement were 
clinical and included such things as ward behavior, 
sociability, orderliness, etc. They noted that chlorpro-
mazine works faster than reserpine but that "improvement - in 
affect and behavior was significantly greater than improve-
ment in ideationu. The dosage given to the patients was a 
minimum of 200 milligrams a day. Another study by Barsa and 
Kline 11 compared three groups, with 150 chronically disturbed 
psychotic female patients in each group, on chlorpromazine, 
reserpine and combined chlorpromazine-reserpine therapy. 
These patients had been previously treated unsuccessfully 
with insulin coma andjor electroshock therapy. Dosage was 
started at 25 milligrams three or four times a day and 
reached an average daily dose of 600 milligrams a day. In 
some patients the dosage was as high as 1800 milligrams a 
day. The results varied from 26 per cent improvement among 
those treated with chlorpromazine alone to 21.3 per cent 
improvement among those treated with reserpine alone. 
Improvement of patients treated with combined therapy was 
smaller (23 per cent) than improvement in those treated with 
chlorpromazine alone. In this study discharge from the 
hospital was the criterion for improvement. 
11. J.A. Barsa ~ and N.S. Kline. A comparative study 
of reserpine, chlorpromazine and combined therapy. A.M.A. 
Archives of Neurology and Psychiatry, 1956, 76, pp. 90-97. 
6. 
Numerous other studies, including those by Tenenblatt 
and Spagno, 12 Rockmore et al., 13 Boardman et al., 14 Shepherd 
and Watt, 15 and Dukay, 16 revealed improvement in psychotic 
patients. Despite the variation in percentages of patients 
improved the prominent impression given by the literature is 
one of remissions with the use of chlorpromazine which are 
at least as good, percentage-wise, as those obtained with 
any other treatment procedure ·. Kinross-Wright 17 went beyond 
this statement in a study which indicates the dramatic 
superiority of intensive "Thorazine" therapy in the treatment 
of schizophrenia. In comparing the percentage of patients 
sufficiently recovered to return to their homes after 
12. Sarah Tenenblatt and A. Spagna. A controlled study 
of chlorpromazine therapy in chronic psychotic patients. 
7. 
Journal of Clinical and Experimental Psychopathology and 
Quarterly-Review of paychiatry and Neurology, 1956, l~p. 81-9a. 
13. L. Rockmore, L. Shatin and I. Funk. Response of 
psychiatric patients to massive doses of thorazine: 1. 
Behavioral and clinical analysis. Psychiatric Quarterly, 
1956, 30, PP• 189-203. 
14. R.H. Boardman, J. Lomas and M. Markowe. Insulin 
and chlorpromazine in schizophrenia. Lancet, 1~56, 2, pp. 487-
490. 
15. M. Shepherd and D.C. Watt. A controlled clinical 
study of chlorpromazine and reserpine in schizophrenia. 
Journal of Neurology, Neurosurgery and Psychiatry, 1956, 19, 
PP• 232-235. ---
16. A.P. Dukay. Chlorpromazine in the treatment of 
chronic psychotic patients. Journal of the Michigan Medical 
Society, 1956, 55, pp. 662-670. -- ---
17. V. Kinross-Wright. The intensive chlorpromazine 
treatment of schizophrenia. Ps~chiatric Research Reports of 
the A.P.A., 1955, 1, pp. 330-3~. 
chlorpromazine treatment with a table compiled by Alexanderl8 
on remission rates of patients treated by insulin, electric 
shock and custodial care, he found 88 per cent of the 
patients in his group were able to return home as opposed 
to figures of 61 per .cent, 49 per cent and 29 per cent 
respectively for insu~in, electric shock and custodial care 
reported in Alexander's tables. 
Feldman indicated some scepticism in accepting the 
improvement percentages literally. He · summarized the 
"success-rates" of 37 physicians who evaluated the clinical 
responses of 321 patients re~eiving chlorpromazine. He 
••• was impressed by the marked individual 
variations and degree-of-success by the 37 partici-
pating physicians who had worked under fairly 
standardized conditions with comparable groups of 
patients.l9 
Feldman divided the participating physicians into four 
cate gories ranging from total acceptance (Category I) to 
total rejection of the drug (Category IV). He then compared 
results obtained by physicians in the first three categories 
(physicians in Category IV completely rejected the drug 
program) and found a significant correlation between the 
physician's attitude toward the drug and the number of 
improvements reported. 
18. L. Alexander. Treatment of mental disorders. 
Philadelphia: W. R. Saunders, 1953:-
19. 
research. 
P• 52. 
P. E. Feldman. The personal element in psychiatric 
American Journal of Psychiatry, 1956, 113, l5.·g- 54 9 
B. 
In illustrating the relationship, Feldman made the 
following statement:: 
The treatment-success of one such physician 
(in Category I) shows that 34 of his 44 patients 
showed at least moderate improvement. A profile of 
the treatment-success of a physician in Category III 
shows that only 3 of his 30 patients showed at best 
moderate improvement. Only 2 of his patients have 
been released from the hospital, even though as a 
group his patients had a slightly more favorable 
prognosi~0than those whose physician was in Cate-gory I. · 
The author stated that he presented his findings 
••• with a view to provide statistical corrob-
oration for the universal fact that the prescribing 
physician has a very significant role in the 
effectiveness of a drug, and that in a project 
involving drug evaluation the physician may be an 
uncontrolled variable whic~1may completely negate his clinical observations. · 
There is considerably more agreement regarding the 
effect of chlorpromazine on hyperactivity, assaultiveness 
and destructiveness of psychotic patients. Cohen noted 
that chlorpromazine's capac.ity to convert highly disturbed 
behavior into docile tractibility has remained an impressive 
phenomenon. 22 The decrease in overactivity has had a 
beneficial effect on ward management, at least from the point 
of view of hospital administrative personnel_. Goldman23 
20. Ibid., p. 53. 
21. Ibid., P• 52. 
22.. J .M. Cohen. Effects of chlorpromazine in psychi-
atric disorders. American Journal of Medical Science, 
1955, 229, pp. 119-126. . -
23. D. Goldman. Chlorpromazine treatment of hospital-
ized psychotic patients. Journal of Clinical and Exteri-
mental Psychopatholo~ and Quarteri;Y Review of-psych atry 
and Neurology, 1956, 7, pp. 45-56. 
investigated the effects of chlorpromazine on the use of 
restraints in the male "violent ward" of a state hospital. 
Using dosages beginning at 50 milligrams t.i.d. or q.i.d. 
and increasing them up to 500 milligrams q.i.d. he found 
decreases in use of restraints from an average of 11.6 
patients per day in restraint at the beginning of the study 
to less than 1.0 patients in restraint per day at the conclu-
sion of the study 14 months later. 
Findings of reduced hyperactivity also have been obtained 
with disturbed children. 24 Bein and Herold, choosing twenty 
disturbed children, divided them into two groups matched for 
age, sex and I.Q. One group was given 75 milligrams of 
chlorpromazine per day and the control group was given 
placebos. Prior to therapy 
••• their behavior was characterized by temper 
tantrums, fighting, overactivity, boisterousness 
and destructiveness to property. They could not 
make the minimum adjustment to their classroom 
tasks, their job placements, or their cottage life.25 
Vast behavioral differences were noted in the experimental 
group af~er two months of chlorpromazine. An additional 
finding was an average increase of 10.4 points in I.Q. for 
the experimental group compared to an average increase of 
~5 points in the control group. The authors state that 
24. H.V. Bain and W. Herold. Efficacy of chlorpro-
mazine in hyperactive mentally retarded children. A.M.A. 
Archives of Neurology and Psychiatry, 1955, 76, pp. 363-364. 
25. Ibid., P• 363 . 
. --
10. 
the rise in I .Q• 
••• may be attributed to the removal of severe 
emotional disorders that had prevented the students 
from functioning at their true level of mental 
ability.26 
Freed and Peifer, 27 varying their dosage level between 
75 milligrams per day and 300 milligrams per day, found 
decreas ed hyperactivity and assaultiveness and "increased" 
willingness to learn in a group of disturbed children. 
Flaherty28 found similar results in a group of 16 children 
whom he described as showing "diminished a ggression and 
hos ti li ty and better contro 1 over impulses 11 • 
B. Neurological and Physiological Research 
Neurological studies suggest that chlorpromazine has 
a depressing or sedative effect on both the central and 
autonomic nervous systems. In discussing the effect of 
chlorpromazine on body temperature McCormick29 noted that 
it has a far more powerful effect than many drugs previously 
used in producing artificial hypothermia. 
26. Ibid., P• 364. 
27. H~ F~eed and C.A. Peifer. Some considerations on 
the use of chlorpromazine in a child psychiatry clinic. 
Journal of Clinical and Experimental Psychopathology and 
Quarterly-Review of PS;fchiatry and Neurology, 1956, l~pp. 164-
169. 
28. J.A. Flaherty. Effect of chlorpromazine medication 
on chilcren with severe emotional disturbances. Delaware 
State Medical Journal, 1955, 27, pp. 189-184. 
29. v.o. McCormick. Largactil in Anaesthesia. Irish 
Journal of Medical Science, 1955, 6, pp. 406-409. 
11. 
Various hypotheses have been advanced to explain 
this effect but none of them is satisfactory. The 
claim that the drug causes an autonomic blockade is 
of importance as it has claimed to be an advantage 
in preventing shock. Chlorpromazine also has a 
marked effect in abolishing or reversing the effect 
of adrenaline on the bloo~0pressure and reducing its vaso-constrictor effect. 
In a survey of the literature Munch-Petersen31 
summarized a number of relevant neurological and biochemical 
studies. One such study by Foster et al. demonstrated the 
peripheral vasa-dilative effects of chlorpromazine on the 
hands, forearms and lower legs of human subjects. In the 
same article a study by Malmejac et al. in which 
••• in addition to the central effects, chlorpromazine 
. also exerted a peripheral inhibitory effect on the 
adrenelino-secretory system and on ~he vasomotor 
systems of the kidney and spleen. 3 
The anti-adrenaline effect of chlorpromazine was confirmed 
by Kornesa and Armitage. 33 Interference with the produc-
tion of adrenaline may be an important factor in diminished 
motor responses noted in studies on chlorpromazine. 
Another important finding in regard to motor function-
ing is reported by Dasgupta and Werner34 who found that 
30. Ibid., p. 406. 
31. Sven Munch-Petersen. Effects of chlorpromazine 
(Largactil) and reserpine (Serpasil) within the field of 
neurology. Acta Ps\chiatrica et Neurologies Scandinavica, 
1956, Supplementum 68, pp. 2~-281. 
32. Ibid., P• 275. 
33. Ibid., P• 275. 
34. Ibid., p. 272. 
12. 
chlorpromazine inhibits the motor activity induced by 
electrical stimulation of the cortex and that it suppresses 
the changes in posture of animals which are otherwise 
excited by stimulation of the cortex, cerebellar nuclei 
and the reticular formation of the brain stem. The authors 
also noted that in decorticated animals, in which central 
factors facilitating reaction from the spinal cord were 
absent, the inhibiting effect of chlorpromazine on the 
spinal cord was much less pronounced. 
Grenell et a1. 35 performed· necropsy on brains of 
animals who had had chlorpromazine. They found chlorpro-
mazine to be present in high concentration in the hypothal-
amus and reticular formation and to a somewhat smaller 
degree in the cortex and medulla. The amount of concentra-
tion differed significantly from control animals who had 
had no chlorpromazine. The same authors reported that 
chlorpromazine "selectively diminished the utilization of 
adenosine triphosphoric acid". Adenosine triphosphoric 
acid is a coenzyme involved in muscle metabolism which is 
utilized in the breakdown of glycogen in muse~~ contrac-
tion. 36 Chlorpromazine also has an antagonistic effect 
on certain drugs which have been used to produce 
35. Ibid., P• 274. 
36. 
delphia: 
B. Harrow. Textbook of Biochemistry. 
W. B. Saunders Co., 1954. 
Phila-
13. 
"experimental psychosis" such as mescaline and lysergic 
37 
acid dimethylamide. 
Thus, physiological and neurolo gics.l research indica.tes 
that chlorpromazine interferes with muscle metabolism and 
sympathetico-adrenal functioning as well as concentrating 
itself in areas of the central nervous system such as the 
reticular format i on through which descending pathways from 
the motor areas of the cerebral cortex to the spinal cord 
pass. In comment ing on these findings Marti-Ibanez et al. 
advanced the following formulation: 
It is postulated that by depressing the autono-
mic nervous system and interfering with the synap-
tic transmission of excessive psychomotor 
excitation between the cortical areas and the 
diencephalon chlorpromazine tranquillizes without 
producing narcosis, coma or amnesia.38 
c. Behavioral Research 
The behavioral research reported here relates to the 
effects of chlorpromazine on gross motor activity, 
conditioned responses and psychological test performance. 
Cook et a1. 39 investigated the effect of chlorpromazine 
on spontaneous motor activity and dexedrine induced 
37. F.M. Sturtevant .and V.A. Drill. Effects of 
mescaline in laboratory animals and influence of ataraxics 
on mescaline response. Proceedings of the Societ~ for 
Experimental Biology and Medicine, 19'56-;-9'2··, pp. !3 ~8. 
38. Marti-Ibanez, Sackler, Sackler and Sackler, 
££• cit., p. 18. 
39. L. Cook, E.F. Weidley, R. W. Morris and P.A. Mattis. 
Neuropharmacological and behavioral effects of chlorpro-
mazine (thorazine hydrochloride}. Journal of Pharmacology 
and Experimental Therapeutics, 1955, 113, pp. 87-94. 
14. 
stimulation in mice as well as its effect on a conditioned 
response in rats. Chlorpromazine in dosage levels from 
3 to 5 mg/kg orally depressed the spontaneous motor activity 
in mice and in dosage of 1.5 mg/kg subcutaneously antagonized 
dexedrine-induced stimulation. Chlorpromazine in doses of 
2 and 10 mg/kg subcutaneously blocked a developed condi-
tioned response in 45 per cent and 80 per cent respectively 
of a group of trained rats. Courvoisier40 trained a group 
of rats to generate an aversive response to an electrified 
floor by climbing a rope to a rest platform. She used a 
bell as the conditioned stimulus. After a number of trials 
the animals completed the course in two to three seconds. 
She measured both the speed of response to the conditioned 
stimulus (bell) and speed of climbing the rope. Chlorpro-
mazine in dosage levels of 1.0 to 5.0 mg/kg diminished both 
speed of rope-climbing and speed of response to the condi-
tioned stimulus. At 10 mg/kg the responses were totally 
inhibited. Phenobarbital, butabarbital and morphine in 
comparable doses had no effect while promethazine, an anti-
histaminic drug, had a mild inhibiting effect at the 
higher dosage level. 
In a similar study the same author placed mice on a 
plate heated to 61°C (141.8° F) and observed their behavior. 
40. Simone Courvoisier. Pharmacodynamic basis for the 
use of chlorpromazine in psychiatry. Journal of Clinical 
and Ex~rimental Psychopathology and QuarterlylReview of 
P8ychia ry and Neurology, 1956, 17, pp. 25-37. --
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She found that in 7 seconds they began licking their palms; 
in 15 to 20 seconds they showed "disordered agitation" in 
the form of •frantic running around" and in 30 to 40 seconds 
exhibited violent vertical leaps "which indicated the percep-
tion of insupportable pain11 • With chlorpromazine the first 
two responses dropped out and only the vertical leaps 
appeared "in exactly _30 to 40 seconds without any premoni-
tory pain". 
Archer41 trained rats to run a multiple-T maze . 
containing 12 correct and 38 incorrect turns until their 
performance was •nearly errorless and their speed predict-
able". A 24-hour thirst was the motivation and water the 
reinforcing stimulus. 
Subcutaneous injection of 0.5 and 10 mg/kg 
of chlorpromazine HCl or an equivalent volume of 
0.9% NaCl was made 45 minutes before trained rats 
were placed in the maze • . · 'rhe smaller dose, which 
compares with large oral dosage in man, has little 
effect on number of errors or speed, although 
individual rats may show less accuracy and speed. 
The larger dose has a considerable effect in de-
creasing speed of most rats although locomotion is 
not seriously affected; the effect on number of 
errors is much less. 42control rats show no aberra-tion of performance. 
In evaluating Archer's results it is important to note 
that minimal oral dose in man is approximately .36 mg/kg 
for a 150 lb. man and that standard oral dosages range as 
41. J.D. Archer. Effects of chlorpromazine on maze 
performance of albino rats. Federation Proceedings, 1954, 
13, p. 332. 
42. Ibid., p. 332. 
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high as 7 or 8 mg/kg. In addition studies by Bower, 
Altschule and Cook43 indicated that maximum blocking of a 
conditioned response occurred at 2 and 2t hours respectively 
after subcutaneous injection of chlorpromazine. While these 
findings do not negate Archer's results they do restrict 
the generalizations which can be made from them. 
Regarding psychological test reactions, Shatin, Rock-
more and Funk44 compared the effects of chlorpromazine and 
sodium aminobarbital on the following psychological tests: 
stylus tapping; three hole stylus tapping; rote memory for 
digits; digit symbol substitution; counting backward from 
20 to 1; dynamometer test; word fluency; ability to judge 
the passage of a 20 second time interval; MacQuarrie 
tracing test; Mac~uarrie tapping test; and MacQuarrie 
dotting test. The subjects were 14 male psychotic veterans 
"sufficiently co-operative to engage in psycho logical 
testing". A basal score was established for each test 
prior to initiating the experimental conditions. Thorazine 
dosage was 800 milligrams daily. 
43. W.H. Bower, M.D. Altschule and L. Cook. 
Psychiatric e.xperience with chlorpromazine. American 
Practice and Digest of Treatment, 1955, 6, pp. 90-93. 
44. L~ Shatin, L. Ro ckmore and I. Funk. Response 
of psychiatric patients to massive doses of thorazine. 
II. Psychological test perf ormance a nd comparative drug 
evaluation. Psychiatric Qjuarterly, 1956, 30* pp. 402-416. 
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Statistical tests of the si gnificance of 
differences between mean scores and mean number of 
errors were made for all tests under the three 
experimental conditions: basal vs. sodium amino-
barbital; basal vs. thorazine and sodium amino-
barbital vs. thorazine. In almost every case the 
test performance was superior under thorazine, in 
contrast to sodium aminobarbi tal. Thorazine did 
not result in significantly lowered performance, 
below that obtained under basal conditions, 
whereas sodium aminobarbital consistently yielded 
a decrement of performance. In some few instances 
results obtained with thorazine were significantly 
superior to those obtained under basal conditions. 
Although the patients received doses of thorazine 
massive enough to cause 'wooden' faces, ability to 
engage in fine motoric co-ordinations and higher 
mental functions was not impaired. 45 
A study which seems to contradict Shatin's findings 
was carried out by Karnetsky, Humphries and Ewarts. 46 The 
authors compared the effects of chlorpromazine and three 
other drugs on the following tests: spe~d of addition 
(3 digits); speed of addition (9 digits); modified digit 
symbol test; speed of copying numbers; pursuit rotor; 
tachistoscope discrimination of circle size at .01 and 1.0 
seconds exposure; tactual threshold discrimination (using 
finely graded nylon hairs on the hand) and a 45 item 
symptom questionnaire administered 30, 90, 150 and 210 
minutes after ingestion. Subjects were 10 normal volun-
teers between 18 and 23 years old. Dosage of chlorpro-
mazine was initially 200 and 400 milligrams but was 
45. Ibid., p. 413. 
46. C. Karnetsky, Olgetta Humphries and E.V. Ewarts. 
Comparison of psychological effects of certain centrally 
acting drugs in man. A.M.A. Archiv~~ of Neur ology and 
Psychiatry, 1957, 77, pp. 318-ZZZ. 
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reduced after observations on four subjects to 100 and 
200 milligrams because of severe postural hypotension. 
Tests were administered 75 minutes after ingestion of the 
drug. A lOxlO Latin square design yielded significant 
differences for both drugs and individuals but not for 
days. Under 200 mg. of chlorpromazine, performance on the 
pursuit rotor and digit symbol test was significantly 
impaired in comparison to the other three drugs (Mepiridin 
hydrochloride, secobarbital sodium and lysergic acid 
dimethylamide). In relationsh.ip to placebos,_ the authors 
found that chlorpromazine impairment occurred on all tests 
and increased with dosage. The authors noted that simple 
intellectual tasks were not affected by dosages under 
200 mg. but all tasks were affected at higher dosages. 
The apparent discrepancies between the study by 
Karnetsky et al. on the one hand and those of Lehman et al. 
and Shatin et al. on the other may be partially due to their 
choice of subjects. Normal subjects were used in the 
Karnetsky research while psychotic subjects were used in the 
studies by Lehman and Shatin. The results emphasize the 
importance of specifying the relationships one is measuring 
and suggest that the variable of psychiatric illness should 
be excluded if one wishes to study basic relationships 
between drugs and behavior. 
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Petrie and LeBeau47 compared performance on the MMPI 
of patients under chlorpromazine and patients who had had 
brain operations, either lobotomies or ablations in the 
orbital or cingulum regions. They concluded that the 
results after cingulumectomy were strikingly similar to 
those under chlorpromazine in respect to its pattern of 
personality change. 
Similar conclusions regarding the resemblance between 
the effects of chlorpromazine and those of brain surgery 
were drawn by Por.teus. 48 He retested a group of 22 
psychotic patients who had shown marked social improvement 
after 300 mg/day of chlorpromazine for periods ranging 
from 6 weeks to 4 months. He found that the performances 
on the Porteus Maze Test became poorer in 68 per cent of 
the patients, 13 per cent remained the same and 18 per cent 
improved. The number of subjects in each group were 15, 3 
and 4 respectively and the mean deficit for each patient 
when compared to their scores prior to medication was 2.06 
years. The author concluded that: 
This evidence that chlorpromazine acts as 
a 'pharmacological lobotomy' is summarized by means 
of a review of all important psychosurgical studies 
47. A. Petrie and J. LeBeau. Psychological changes 
in man after chlorpromazine and certain types of brain 
surgery. Journal of Clinical and Experimental Psychopathology 
and Quarterly Review of Psychis:tr'y and Neurology, 1956, 17, 
'lJI,J." 1'70-1'79. - --
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48. J.M. Porteus. Maze test reactions after chlor-
promazine. Journal of Consulting Psychology, 1957, 21, pp. 24-
31. 
in which the Porteus Maze Test was used, and the 
deficits found are comparable to those now demon-
strated to ~6llow prolonged chlorpromazine 
medication. 
While the above studies make no pretense of being a 
complete review of the volQminous literature on chlorpro-
mazine, they appear sufficient to suggest that orie of the 
major effects of the drug is a change in gross motor 
behavior. In general the studies indicate that the 
direction of the change is toward retardation. It is the 
purpose of this investigation to select a well defined 
psychomotor response involving fine motor movement and to 
measure precisely the interrelationship between dosage 
level and the response. 
D. Reaction Time 
While this experiment is not designed to study reac-
tion time per se, but rather as a precisely quantifiable 
example of motoric behavior, a brief review of some of 
the salient features on reaction time are presented here 
in order to refresh the reader's memory and to provide 
empirical justification for the statements concerning 
reaction time which appear later in the text. 
The response process involved in reaction time 
ordinarily involves some sort of motoric behavior in response 
to a sensory stimulus. "The reaction time, also called the 
49. Ibid., P• 27. 
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response latency, includes sense organ time, brain time, 
nerve time and muscle time." 50 
Woodworth and Schlossberg, in their discussion of reac-
tion time, point out the necessity of avoiding premature 
responses and responses to the time interval between the 
experimenter's comment "ready" and presentation of the 
stimulus (temporal conditioning). The same authors state 
that when the reaction time ranges from .10 to .20 seconds 
the instrument for measurement should measure in units of 
51 
.01 seconds to achieve the required accuracy of measurement. 
The authors also state that some improvement occurs 
with practice "although the amount of improvement is 
certainly not large after the first 50 or 100 trials". 52 
King53 in his comparison of reaction times of normal 
subjects and schizophrenic subjects found that the effects 
of practice were minimal after 20 or 30 trials. Forbes54 
found no relationship between practice and auditory reaction 
time in 178 subjects. 
50. R.S. Woodworth and H. Schlossberg. Experimental 
psychology. New York: Henry Holt & Co., 1954. 
51. Ibid., P• 11. 
52. Ibid., P• 35. 
53. H.E. King. Psychomotor ~ectsof mental disease. 
Cambridge: Harvard University Press,~4. 
54. G. Forbes. The effect of certain variables on 
visual and auditory reaction time. Journal of Experimental 
Psychology, 1945, 35, pp. 346-349. 
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Both authors cite age and mental illness as variables 
producing lengthening reaction time although Woodworth and 
Schlossberg state that "the effect of old age is less marked 
on reaction time than in many other tests of motor speed and 
agi li ty 11 • 55 King found the reaction times of schizophrenic 
subjects to be significantly slower than reaction time of 
normal subjects. Studies reported in Woodworth and Schloss-
berg found a "rather long reaction time" in both schizo-
phrenic patients and manic-depressive patients. Woodworth 
and Schlossberg also emphasize the day to day and hour to 
hour oscillations in reaction time which aruns to about 10 -
13 per cent of his mean reaction time under the most favor-
able conditions. 56 This would seem to indicate the need for 
establishing a daily base line and taking measurements 
across time intervals in order to secure a representative 
sample of responses. 
The same authors also point out that because of a 
minimum physiological limit the distribution of reaction 
times are skewed and should be converted to logarithmic 
units to correct the skewness of the distribution and 
stabilize the variance. 
Some drug studies have b~en reported. Thornton, Holck 
and Smith investigated the effects of caffeine, benzedrine 
55. R.S. · Woodworth and H. Schlossberg, ££• cit., p. 36. 
56. Ibid., p. 18. 
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and placebos on a number of motoric tasks. 57 Using repeated 
measurements on the same subject and with an N of 3 subjects 
they found no reliable differences as a result of the three 
drugs. Testing was done 90 minutes after drug ingestion. 
Impairment has been noted as a function of anoxia and 
brain damage. 58 
In general studies on reaction time with normal individ-
uals have revealed that 
•••• performance may be assumed to be relatively free 
of connection with other characteristics of the 
individual, such as intelligence, occupation, cul-
ture, socio-eg6nomic status, education, language 
ability, etc. 
Although there are, of course, individual dif'ferences in 
reaction time King found remarkably little variability in 
his group of 194 normal subjects except in the hi gher age 
group .60 
On the basis of the literature reviewed above experi-
mental precautions to avoid anticipatory responses and 
temporal conditioning were taken. It was felt that 40 prac-
tice trials would be sufficient for stabilization of the 
response. A daily base line prior to drug ingestion was 
established to take into account day to day variations in 
reaction time. 
57. G.R. Thornton, H.G. Holck and E.L. Smith. The 
effect of benzedrine and caffeine upon performance in certain 
psychomotor tasks. Journal of Abnormal and Social Psychology, 
1939, 34~ 
58. H.E. King, £E.· cit., p. 141. 
59. Ibid., P• 52. 
60. Ibid., P• 53. 
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CHAP'I'ER III 
STATEMENT OF THE PROBLEM 
The studies cited above by Cook et al., Courvoisier, 
Archer and others on research with animals all demonstrate 
interference with motor performance under fairly large 
dosages of chlorpromazine. Studies by Karnetsky et al. and 
Porteus have demonstrated the same findings in humans 
although studies by Lehman and Hanrahan and Shatin et al. 
offer someWhat contradictory evidence. Clinically, one of 
the major findings has been diminished assaultive and des-
tructive behavior. · These findings permit the generation of 
the following hypotheses regarding chlorpromazine and fine 
motor behavior. Reaction Time was chosen as the fine motor 
response in this experiment, partly because it lends itself 
to precise measurement and partly because it appears to be 
relatively slightly influenced by learning, I.~., socio-
economic factors, occupation, etc. 
The first hypothesis and its corollaries were formu-
lated as follows: 
Hypothesis I. Following the ingestion of chlorpro-
mazine, time required to perform a simple motor 
task will be increased. 
Corollary A. Simple reaction time will increase 
following ingestion of chlorpromazine. 
Corollary B. The increase in simple reaction 
time will vary directly with the amount of 
dosage. 
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The relationship between chlorpromazine and sensory or 
intellectual functioning is a more subtle one. The study 
reported above by Karnetsky et al. found that simple 
intellectual tasks were not interfered with by low dosages 
of chlorpromazine. This was in contrast to motor responses. 
At high dosage levels, however, both types of responses were 
impaired. In general, studies with clinical groups revealed 
improvement or no change in sensory functioning with abnormal 
groups. Since a sensory discrimination plays a large role 
in disjunctive reaction time and since the literature 
suggests that sensory functioning is not impaired at low 
dosages, the second hypothesis and its corollaries were 
formulated as follows: 
Hypothesis II. Disjunctive reaction time will be less 
affected than simple reaction time by ingestion 
of chlorpromazine. 
Corollary A. Disjunctive reaction time will be 
unaffected by low dosage levels of chlorpro-
mazine. 
Corollary B. Significant impairment of disjunc-
tive reaction time wi 11 occur at a higher 
dosage level than the dosage required for 
significant increase in simple reaction time 
(Critical Dosage). 
Corollary C. At the higher dosage leve 1s, dis junc-
tive reaction time will increase as a 
positive function of dosage. 
In measuring the relationship between chlorpromazine 
and reaction time the method of repeated measurement of the 
same subject was used. This permitted an intensive investi-
gation of the relationship between dosage and reaction time 
as well as evaluation of changes in the response over a 
period of time. 
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CHAPTER IV 
EXPEF.I MENTAL METHODS AND PROCEDURE 
This experiment was designed to measure the relation-
ship between two independent variables; dosage level of 
chlorpromazine and time after administration of the drug, 
and the dependent variable, reaction time. 
A. Variables 
The dosage levels of the drug chlorpromazine hydro-
chloride (Thorazine} were varied between zero and 150 mgm. 
They were given at the same time on each day in identical 
appearing capsules, three capsules in each administration. 
Following a day of practice, placebos were administered to 
the subjects at the next testing session. In the first stage 
of the study medication was begun at 25 milligrams and 
increased in increments of 25 milligrams up to the maximum 
of 150 milligrams. A higher maximum dosage level was 
ori gi nally contemplated, but was abandoned because of the 
subjects' extreme drowsiness at 150 mgm. This procedure 
of gradual increase in dosage was necessary for medical 
reasons. Although the subjects were told that the drug was 
"Thorazine" they were unaware of dosage level because 
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of the identical appearance of all the capsules. Following 
the first series consisting of a placebo, six dosage levels 
of chlorpromazine and one day with no drug, the procedure 
was replicated with the dosages being present in random 
order. Randomization was done by an indivudial other than 
the experimenter, and. the latter was unaware of dosage 
level. 
The second independent variable, time after drug adminis-
tration, was introduced primarily because the time interval 
between drug administration and peak effect of the drug had 
not been established. By taking responses over a period of 
time the experimenter avoided obscuring results by testing 
at the wrong time and, in addition, hoped to measure more 
precisely the interaction between time after administration 
and the effects of the drug on psychomotor response. 
Measurements of reaction time were taken prior to adminis-
tration of the drug, one hour after drug administration and 
each half-hour thereafter with the final reading of the day 
occurring at three and one-half hours after drug administra-
tion. 
The dependent variable was the time to respond to an 
auditory stimulus signalled by pressing a telegraph key. 
Two types of stimulus conditions were set up to produce a 
simple motor response to a bell or buzzer (simple reaction 
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time} and a sensory discrimination plus a motor response 
(disjunctive or complex reaction time}. The response was 
the same for both sets of conditions except that in the 
case of disjunctive reaction time a sensory discrimination 
preceded the motor response. 
B. Subjects 
Tpe subjects were two normal adult white males selected 
from a group of volunteers at Boston State Hospital. They 
were screened both by psychological tests and psychiatric 
interview to eliminate disturbed individuals and thus avoid 
complicating the response process with the uncontrolled 
variable of psychiatric illness. They were paid $1.00 an 
hour and it was assumed that their conscious motivation was 
constant. 
c. Apparatus 
A standard reaction time apparatus was used. The 
apparatus was so designed that a switch served to activate 
both the auditory stimulus (a bell or a buzzer) and the 
chronoscope, which permitted time measurement in units of 
.01 seconds. A telegraph key, when pressed, simultaneously 
stopped the chronoscope and the auditory stimulus. The sub-
ject sat in the same position each time with his hands 
resting on two knobs directly in front of him. The only 
other parts of the apparatus visible to the subject were 
part of the frame and the two telegraph keys. The 
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experimenter sat opposite the subject with three switches and 
the chronoscope in front of him. One switch activated the 
buzzer, another the bell and the third switch was used as a 
dummy. 
D. Procedure 
The subjects reported at 5:00 P.M. every other day. On 
the first day of testing they familiarized themselves with 
the apparatus. A sufficient number of practice trials were 
administered for the subjects to achieve a stable response. 
Following this day of practice the experiment proper began. 
On the first day of the actual experiment, the subjects 
were tested as soon as they reported. They were required to 
perform ten simple reaction time respo~ses with their left 
hand, ten simple reaction time responses with their right 
hand and ten disjunctive reaction time responses. The total 
of thirty reaction time responses was considered one testing 
period. There were seven such testing periods at regular 
intervals on each day of the experiment. After they 
completed the first testing period they were given three 
identical appearing capsules, all of which contained place-
bos. They were then permitted to eat. One hour after the 
capsules had been administered the second testing period of 
the day began. The same procedure was followed except that 
the order of performance of the three tasks was changed to 
control for any systematic interference by fatigue or prac-
tice. Following this testing period the subjects rested for 
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25 minutes. One and one-half hours after administration of 
the capsules the third testing period began. At each 
succeeding half hour another testing period occurred until, 
at three and one-half hours after administration of the 
capsules, the last testing period of the day took place. 
This made a total of seven testing periods, one of which 
occurred prior to administration of the capsules and six of 
which occurred following administration of the capsules. On 
each day of testing there were twenty simple and ten disjunc-
tive reaction time responses prior to drug administration 
and 120 simple and 60 disjunctive reaction time responses 
taken after drug administration. Following the last testing 
period of the day, the subjects were dismissed and asked to 
return in two days at the same time. 
On the second day of the experiment the same procedure 
was followed except that the three identical appearing 
capsules contained a total of 25 milligrams of chlorpromazine. 
On each succeeding experimental day the dos .age of chlorpro-
mazine was increased by 25 milligrams until the dosage of 
150 milligrams was reached on the seventh day of testing. 
These se~an experimental days constituted the first part of 
the experiment and w~referred to as the single-blind series. 
Following the single-blind series the subjects were tested 
without drug under the same procedure outlined above. 
The second part of the study was a replication of the 
first except that this time the order of dosage presentation 
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was randomized and neither subjects nor experimenter knew 
the contents of the three .capsules which were administered 
on each experimental day. Seyen experimental days consti-
tuted the second part of the experiment and this second series 
was called the double-blind series. The purpose of concealing 
the contents of the drug from .the subjects (single-blind) and 
both the subjects and the experimenter (double-blind) w.as to 
prevent the interference of suggestion in the response 
process. This precaution was felt to be necessary even though 
the measurements were objective and the subjects had no way 
of knowing how well or how poorly they were doing. 
Following the double-blind series the subjects were 
tested for three more days. This time they were offered 
double pay if they could improve their performance by ten 
per cent. A placebo, 75 milligrams and 150 milligrams were 
used as the dosages. This series was called the double-
reward series. Results were compared statistically to provide 
a partial test of the assumption of constant conscious 
motivation. 
During the 25 minute rest period the subjects'behavior 
was not controlled except that they were denied drugs or 
stimulants, including tea and coffee. For the most part 
they occupied themselves playing cribbage, reading and, at 
the higher dosage levels, sleeping. They were advised 
against using alcohol during the duration of the experiment 
because of the known potentiating effects of chlorpromazine 
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on central nervous system depressants. 61 They were 
encouraged to get a good night's sleep, to avoid driving 
on evenings they had taken the drug and to report any time 
they had taken any other drug. They were followed closely 
medically. As far as the experimenter knows the subjects 
c onformed remarkably well to the requests made of them. 
The interval between the ready signal and presentation 
of the stimulus varied between 1 and 5 seconds to avoid 
temporal conditioning. The d~y switch was used to dis-
courage antic i patory responses. A copy of the instructions 
given to the subjects may be found in Appendix A. 
61. J.D. Schultz, E.L. Rea, J.F. Fazeka and J. Shea. 
Chloppromazine in the management of acute alcoholic states. 
Quarterly Journal of Studies ~Alcohol, 1955, 16, pp. 31-38. 
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CHAPTER V 
RESULTS 
The experimental results confirmed the general, hypo-
thesis that reaction time would be increased following 
ingestion of chlorpromazine. The prediction that increase 
in simple reaction time would occur as a positive function 
of increased dosage of chlorpromazine was also confirmed. 
The prediction that disjunctive reaction time would be less 
affected than simple reaction time by chlorpromazine at low 
dosages was supported. The prediction that disjunctive 
reaction time would be increased at high dosage levels of 
chlorpromazine was confirmed. 
A. Effect of Dosage 
The prediction that simple reaction time would increase 
following ingestion of chlorpromazine and that increase in 
reaction time would occur as a positive function of dosage 
was confirmed by the performance of both subjects. The 
results are presented in Table I. In Table I the mean simple 
reaction times, pre-drug and post-drug, are given for both 
subjects. The unit of measurement is .01 seconds. Each pre-
drug mean reaction time is an average of 20 responses. Each 
post-drug mean reaction time is an average of 120 responses. 
Data are presented for the single-blind and double-blind 
series. Figures 1 and 2 illustrate the relationship 
34. 
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Table I 
Mean Reaction Time, Simple 
Single-Blind Double-Blind 
Dosage Pre-Drug Post-Drug Pre-Drug Post-Drug 
Subject A 
Placebo 28.3 26.8 28.8 30.0 
25 mgm. 27.1 29.6 26.5 30.1 
50 mgm. 25.8 28.9 26.0 30.1 
75 mgm. 26.9 30.5 26.0 30.4 
100 mgm. 26.9 28.3 28.5 34.9 
125 mgm. 25.3 32.9 27.4 31.3 
150 mgm. 26.3 35.0 27.3 39.3 
Subject B 
Placebo 34.7 35.4 32.2 32.0 
25 mgm. 35.0 36.0 33.4 32.8 
50 mgm. 32.4 38.5 31.3 32.7 
75 mgm. 35.8 40.0 31.9 36.1 
100 mgm. 32.7 39.8 34.8 34.8 
125 mgm. 36.1 42.4 33.1 34.8 
150 mgm. 33.0 52.1 35.2 43.2 
Figure 1. 
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Figure 2. Mean reaction time, simple vs. dosage. Subject B. 
between dosage of chlorpromazine and reaction time for 
subjects A and B respectively. Curves .are plotted for the 
single-blind and double-blind parts of the study as well as 
for the combined average. It may be observed that reaction 
time increases as a positive non-linear function of dosage 
fo~ both subjects. In all cases the mean reaction time after 
drug administration is higher than the mean reaction time 
under placebo. The reaction times on the graphs represent 
the average of all post-drug measurements of simple reaction 
time. Mean reaction times for left hand and right hand did 
not differ from each other (see Figures 9 and 10, Appendix ~) 
and were, therefore, combined in the preparation of Figures 
l and 2. 
The replication of the testing procedure in the double-
blind part of the experiment resulted in a similar relation-
ship between the dosage level and reaction time although 
there was some variation in the absolute values of reaction 
time. Since one subject's performance improved while the 
other subject's was somewhat poorer this variation is probably 
a chance occurrence. The percentage of change from pre-drug 
levels in mean reaction time varies from a low of about 3 per 
cent for subject A under 50 mgm. (Figure l) to a high of 
almost 50 per cent for subject B under 150 milligrams 
(Figure 2). The marked effect of 150 milligrams on the sub-
jects is illustrated by the steepness of the curve from 125 
to 150 milligrams. This finding was also apparent in the 
subject's general behavior under 150 milligrams. 
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The changes in simple reaction time under the several 
dosage levels of chlorpromazine were tested statistically by 
analysis of variance. Separate analyses of variance were 
done for each subject, under each method of dosage administra-
tion and for ~ach type of response. For example, one 
analysis of variance was done for subject A, single blind 
method, left hand simple reaction time. Another analysis 
of variance dealt with subject A, single blind method, right 
hand simple reaction time. A total of eight analyses of 
variance were carried out on the data on simple reaction 
time. 
Because inspection of the data revealed a mild positive 
skewness, the raw scores were converted to logarithms. In 
addition to the variance contributed by dosage, the variances 
contributed by the measurements at the several time intervals 
after drug administration as well as the interaction of 
dosage and time after drug administration were extracted. 
The variance contributed by dosage was found to be 
significantly greater than chance variation in all eight 
analyses of variance on simple reaction time. In each case 
the probability of the dosage variance occurring by chance 
was less than .001. On this basis the hypothesis that 
following the ingestion of chlorpromazine, time required to 
perform a simple motor task will be increased is tenable. 
The results of the eight analyses of variance on simple 
reaction time are presented in Tables VIII through XV in 
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Appendic c. Inspection of Figures 1 and 2 confirmed the 
hypothesis that simple reaction time increases as a positive 
function of dosage. 
For disjunctive reaction time the subjects were required 
to respond to a bell with their left hand and a buzzer with 
their right hand. The same conditions of drug administration 
as were described above were followed. 
It was expected that disjunctive reaction time would be 
less affected by small doses of chlorpromazine than would 
simple reaction time. This expectation was based on 
Karnetsky's study, reported above, which indicated that the 
relationship between chlorpromazine and sensory functioning 
is one in which sensory functioning is not impaired at low 
dosage levels. It was expected that at higher dosage levels 
of chlorpromazine disjunctive reaction time would increase. 
The data are presented in Table II. The mean disjunc-
tive reaction times, pre-drug and post-drug, are given for · 
both subjects. The unit of measurement is .01 seconds. 
Each pre-drug mean reaction time is an average of ten 
responses. Each post-drug mean reaction time is an average 
of 60 responses. Data are presented for the single-blind 
and double-blind series. Figures 3 and 4 illustrate the 
relationship between chlorpromazine and disjunctive reaction 
time. The curves show a greater variability than they do 
for simple reaction time but the general relationship is 
one in which the mean disjunctive reaction time increases: 
as a function of increases in dosage of chlorpromazine. 
Change in disjunctive reaction time is more dramatic 
40. 
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Table II 
Mean Reaction Time, Disjunctive 
Single-Blind Double-Blind 
Dosage Pre-Drug Post-Drug Pre-Drug Post-Drug 
Subject A 
Placebo 49.0 42.8 43.0 40.5 
25 mgm. 45.6 47.3 39.7 42.4 
50 mgm. 48.1 49.8 37.9 40.8 
75 mgm. 42.2 45.7 39.7 40.8 
100 mgm. 45.5 44.8 47.5 50.3 
125 mgm. 44.5 50.1 40.2 45.6 
150 mgm. 39.2 52.1 42.2 52.0 
Subject B 
Placebo 67.3 62.6 52.5 48.3 
25 mgm. 48.1 58.9 59.1 57.0 
50 mgm. 54.1 62.4 50.9 48.9 
75 mgm. 57.8 63.2 53.0 58.0 
100 mgm. 58.1 66.8 46.9 50.7 
125 mgm. 56.0 69.4 49.8 49.6 
150 mgm. 55.0 80.3 57.0 66.4 
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for subject A than for subject B although both subjects show 
rather striking impairment at a dosage of 150 milligrams. 
~~en the curves are taken separately it can be seen that 
both the single-blind and double-blind curves for subject A 
and the double-blind curve for subject B show relatively 
less impairment of disjunctive reaction time at lower dosage 
levels than do the curves for simple reaction time. 
Separate analysis of variance were done for each 
subject and for both the single and double blind series. 
This made a total of four analyses of variance for disjunc-
tive reaction time. The variance contributed by dosage was 
found to be significantly greater than chance variation in 
all four analyses of variance. In each case the probability 
of the dosage variance occurring by chance was less than 
.001. On this basis the hypothesis that following the inges-
tion of chlorpromazine disjunctive reaction time will 
increase was confirmed. The results of the four analyses of 
variance are presented in Tables XVI through XIX in Appendix 
D. 
Direct comparisons of the means of simple reaction times 
with the means of disjunctive reaction times is not possible 
since they come from different populations with different 
variances. 'rhe important comparison, for purposes of this 
study~ involves differential effect of chlorpromazine on 
simple and disjunctive reaction times. To assess the 
presence or absence of differential change pre-drug and 
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post-drug means were calculated for both subjects under both 
dosage series and for each dosage level of chlorpromazine 
from 25 to 150 milligrams. The percent change in reaction 
time from pre-drug to post-drug conditions was then cal-
culated. These results are presented in Table III. 
Changes of 10 per cent or more from pre-drug to post-
drug conditions occurred more frequently in the case of simple 
reaction time than in the case of disjunctive reaction time. 
Table IV presents a chi-square test for the independence from 
type of task of changes of less than 10 per cent and greater 
than 10 per cent for disjunctive reaction time and simple 
reaction time for all dosage levels of chlorpromazine. 
The obtained x2 values .of 5.57 and 0.65 for subjects A 
and B respectively yielded probability values of .018 and 
o.42. When these probabilities were combined . the obtained 
value was not significant at the .05 level. 
When only dosages of 100 milligrams or less are included, 
the obtained x2 values for subjects A and B are 8.82 and 0.90 
respectively and yield probability values of .OOJ and o.JJ 
respectively. These probabilities, when combined, yield an 
overall probability of less than .01. These results, 
presented in Table V, while certainly not conclusive, lend 
support to the experimentaL prediction that disjunctive 
reaction time would be less affected than simple reacti on 
time by ingestion of chlorpromazine in low dosages. In 
addition, if the point at which more than ~- of the post-
drug reaction time increase 10 per cent or more is estab-
lished as the point at which it can be said that the drug 
has a definite effect, then it can be observed that this 
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Table III 
% Change in Reaction Time from Pre-Drug to 
Post-Drug Conditions 
Simple Disjunctive 
Reaction Time Reaction Time 
$ubject Series Dosage J;re- Post.;. Change Ere- Post- G. 1ange 
Drug Drug Greater Drug Drug Greater 
Mean Mean Than Mean Mean Than 
10% 10% 
A Single blind 25 mgm 27.1 29.6 45.6 47.3 
-A Double blind 26.6 30.1 ~~-- 39.7 42.4 
B Single blind 35.1 36.0 48.1 58.9 
* 
B Double blind 33.4 32.8 59.1 57.0 
A Single blind 50 mgm 25.8 28.9 
* 
48.1 49.8 
A Double blind 26.1 30.1 
* 
37.9 40.8 
B Single blind 32.4 38.5 
* 
50.9 48.9 
B Double blind 31.3 32.7 50.9 48.9 
A Single blind 75 mgm 26.9 30.5 ·;!- 42.4 45.7 
A Double blind 26.0 30.1 
* 
39.7 40.8 
B Single blind 35.8 40.0 
* 
56.8 63.2 
* 
B Double blind 31.9 36.1 
* 
53.0 58.0 
A Single blind 100 mgm 26.9 29.3 45.5 44.8 
A Double blind 28.6 34.9 
* 
47.5 50.3 
B Single blind 32.7 39.8 
* 
58.1 66.8 
* 
B Double blind 34.8 34.8 46.9 50.7 
A Single blind 125 mg}Il 26.3 . 32.9 
* 
44.5 50.1 
* 
A Double blind 27.4 31.3 
* 
40.2 45.6 
* 
B Single blind 36.1 42.3 ~~- 56.0 69.4 .o3!-
B Double blind 33.1 34.7 49.8 49.6 
A Single blind 150 m@Il 25.3 35.0 ~ .. 39.2 52.1 
* 
A Double blind 27.2 39.3 
* 
42.2 52.0 
* 
B Single blind 33.0 52.1 
* 
57.0 80.3 
* 
B Double blind 
1 
35.2 43.2 
* 
55.0 66.4 
* 
Table IV 
Chi Square Test for .Independence from Type of Task of 
Changes of 10% in Mean Reaction Time After 
Drug Administration (All Dosage Levels). 
Type of Task Change 
Less Than 
10% 
Change 
Greater Than 
10% 
Total 
Subject A 
Simple 
Reaction Time 2 
Dis june ti ve 
Reaction Time 8 
Total 10 
x2 = 5.57 
df = 1 
p - .018 
Subject B 
Simple 
Reaction Time 5 
Dis june ti ve 
6 Reaction Time 
Total 11 
x2 
= 0.65 
df = 1 
p = 0.42 
Combined Probability = 
10 
4 
14 
7 
6 
1.3 
> .05 
< .10 
12 
12 
12 
12 
Table V 
Chi Square Test for Independence from Type of Task 
of Changes of 10% in Reaction Time After Drug 
Administration (100 Milligrams and Lower). 
Type of Task 
Simple 
Reaction Time 
Disjunctive 
Reaction Time 
Total 
Simple 
Reaction Time 
Disjunctive 
Reaction Time 
Total 
Change 
Less Than 
10% 
Subject A 
2 
8 
10 
x2 - 8 . 82 
-
df = 1 
p = .OOJ 
Subject B 
4 
5 
9 
x2 = .903 
df - 1 
P = o.JJ 
Change 
Greater Than 
10% 
6 
0 
6 
4 
7 
Combined Probability = <:.., .01 
48. 
Total 
8 
8 
8 
8 
point occurred at a dosage level of 50 mi l ligrams f or 
simple reaction time in contra.st to a dosage level of 12.5 
milligrams for disjunctive reaction time. On these bases 
the hypothesis that disjunctive reaction time is less 
affected than simple reaction time by ingestion of chlorpro-
mazine is supported. The critical dosage for producing 
increments in reaction time of 10 per cent or more from pre-
drug reaction times is established for these subjects as 50 
milligrams for simple reaction time and 100 milligrams for 
disjunctive reaction time. In view of the small sample and 
limited number of responses these results must be considered 
as suggestive rather than definitive. 
B. Effects of Time After Drug Administration 
Although no experimental predictions were made 
regarding changes in reaction time as a function of the 
passage of time after administration of the drug, it was 
expected that the drug would take some time to achieve its 
maximum effect on reaction time and would then have 
diminishing effect until the response returned to its pre-
drug level. 
In Table VI the mean simple reaction time at each 
interval of time after drug administration is presented for 
subjects A and B. The data are further broken down to show 
the mean simple reaction time at each time interval and with 
respect to each amount of dosage of chlorpromazine which 
was administered. The units of measurement are .01 seconds. 
These data are presented graphically in Figures 5 and 6. 
49. 
50. 
Table VI 
Mean Reaction Time, Simple 
Amount Time After Drug Administration 
of Pre- 1 1! 2 J. 2-e 3 3! 
Dosage drug Hour Hours Hours Hours Hours Hours 
. Subject A 
Placebo 28.8 27.7 29.4 28.7 27.3 27.9 29.4 
25 mgm. 26.8 29.5 30.8 29.3 31.5 29.8 29.5 
50 mgm. 25.9 28.5 29.9 30.6 30.2 29.5 30.1 
75 mgm. 26.5 30.4 30.2 31.4 31.2 30.1 28.9 . 
100 mgm. 27.8 30.8 33~7 32.2 24.9 32.0 29.3 
125 mgm. 27.9 29.8 29.5 30.1 32.0 33.4 37.1 
;1.50 mgm. 26.2 32.8 36.5 40.2 39.2 37.1 37.6 
Subject B 
placebo 33.0 32.7 33.5 33.0 32.4 32.6 32.8 
25 mgm. 34.2 37.1 35.0 34.8 33.0 34.3 34.5 
50 mgm. 31.9 34.0 35.7 35.9 36.6 35.0 35.9 
75 mgm. 33.8 33.6 41.2 41.9 40.2 38.2 36.2 
100 mgm. 33.5 32.7 34.6 36.7 38.7 39.3 42.7 
125 mgm. 34.6 35.7 37.4 38.5 41.1 39.3 39.9 
150 mgm. 34.1 36.0 41.5 47.1 55.1 53.3 52.4 
1 
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Each figure contains six small graphs in which the mean 
simple reaction time is plotted across time after drug 
administration for each of the six dosages administered. 
The mean reaction times under chlorpromazine are plotted 
against the mean simple reaction time under placebo. 
The performance of subject A (Figure 5) on dosages from 
25 to 100 milligrams is such that at 3! hours after drug 
administration his mean reaction time closely approximates 
his reaction time under placebo although it does not return 
to its pre-drug level. At dosage levels of 125 and 150 
milligrams the reaction time remains close to its peak 
indicating the prolonged effect of the higher dosages. 
The performance of subject B (Figure 6) under dosages 
up to 75 mgm also tends to approximate the reaction time 
under placebo at 3! hours after drug administration. At 
dosages of 100 to 150 mgm. the same prolonged effects of 
the drug are observed. Although the curves reflect individ-
ual differences such as one might expect in reaction to 
drugs, the effect of the drug over a period of time is 
clearly shown as is the interaction between the amount of 
dosage and the length of time for Which reaction time is 
impaired. 
The variances contributed by measurements at the 
several time intervals were found to be significantly 
greater than chance variation in all eight analyses of 
variance on simple reaction time. In each case the 
53. 
probability of the time variance occurring by chance was 
less than .001. Inspection of Figures 5 and 6 reveal that, 
for the most part, the peak effect occurs from two to two 
and one-half hours after administration of the drug. The 
performances of subject A under 125 milligrams and of 
subject B under 25 and 100 milligrams are exceptions. The 
results of the eight analyses of variance are presented in 
Tables VIII through XV in Appendix C. 
The variance contributed by the interaction of amount 
of dosage and time after drug administration was also 
extracted. This variance was found to be significantly 
greater than chance variation in all eight analyses of 
variance. In each case the probability of the interaction 
variance occurring by chance was less than .001. 
Inspection of the data indicated that the interaction 
was such that at the lower dosage levels the mean simple 
reaction time tends to return close to the pre-drug level 
after three and one-half hours after drug administration. 
In contrast to this at the higher dosage levels impairment 
of the response is prolonged and remains close to its 
slowest value at three and one-half hours after administra-
tion of the drug. High dosages of chlorpromazine therefore 
result in both greater and more prolonged impairment of 
simple reaction time. 
Mean disjunctive reaction time is given for each dosage 
level and each time after drug administration in Table VII. 
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Table VII 
Mean Reaction Time, Dis june ti ve 
Time After Drug Administration Dosage 
Pre- 1 li 2 2~ 3 3~ Level drug Hour Hours Hours Hours Hours Hours 
Subject A 
Placebo 46.6 39.6 40.8 39.1 41.7 44.2 41.3 
25 mgm. 42.6 45.4 42.5 43.5 43.1 4·6 8 . . 47.7 
50 mgm. 43.1 41.4 46.5 41.3 48.9 47.6 43.6 
75 mgm. 39.6 39.6 47.8 46.3 45.5 40.5 39.8 
100 mgm. 46.5 46.4 51.0 49.4 47.7 48.3 46.9 
125 mgm. 42.4 43.8 45 .3 47.3 47.8 46.7 50.1 
150 mgm. 40.6 46.8 5o.4 52.2 56.2 49.5 55.7 
Subject B 
Placebo 53.2 46.9 51.4 48.0 51.5 47.7 47.8 
25 mgm. 53.9 55.6 64.5 56.2 57.7 55.8 57.8 
50 mgm. 52.3 58.8 57.4 55.3 54.9 50.8 55.6 
75 mgm. 55.4 59.8 58.9 67.6 58.5 57.0 56.8 
100 rngrn. 52.5 53.0 58.8 56.9 61.8 51.6 66.2 
125 mgm. 53.2 56.9 59.5 59.3 60.1 61.5 60.6 
150 mgm. 56.0 61.3 69.4 64.0 84.1 77.1 79.2 
The effect of the passage of time on disjunctive reaction 
time is presented in Figures 7 · and 8. Each figure contains 
six small graphs which illustrate the variations in mean 
disjunctive reaction time over the three and one-half hours 
after administration of the drug. In each graph mean disjunc-
tive reaction time under chlorpromazine at each of the six 
dosage levels is compared with mean disjunctive reaction time 
under placebo. The units of measurement are .01 seconds. 
As might be expected disjunctive reaction time is a 
less stable response than simple reaction time and the 
variation over a period of time is greater both under 
placebo and under chlorpromazine. 
For subject A (Fi gure 7) maximum impairment in reaction 
time occurs at four different times. Tendency for recovery 
at three and one-half hours occurs at dosages of 50, 75 and 
100 milligrams and the effects appear prolonged at 25, 125 
and 150 milligrams. Except for the results at 25 mgm these 
findings are similar to the curves of subject A for simple 
reaction time. There is a tendency for the peak effects to 
occur later at the higher dosage levels although this is not 
as clear as it is in the case of simple reaction time. 
The curves for subject B (Figure 8} are quite similar 
for both disjunctive and simple reaction time. Again the 
peak effect appears relatively early at the low dosage levels 
and then reaction time returns close to its pre-drug value. 
At the higher dosage levels the peaks appear at a later time 
56. 
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and the response does not return to its pre-drug level. 
The variances contributed by measurements at the several 
time intervals were found to be significantly greater than 
chance variation in two of the four analyses of variance on 
disjunctive reaction time. The four analyses of variance 
yielded F ratios whose probabilities of occurrence by chance 
were 0.15, .0015, .001, and 0.35, respectively. Combination 
of the probabilities using a chi-square transformation 
yielded an overall probability of less than .001.62 These 
analyses of variance are presented in Tables XVI through 
XIX in Appendix D. 
The analyses of variance for the interaction effect of 
time after drug administration and amount of dosage on 
disjunctive reaction time resulted in F ratios with 
probability levels of 0.10, .0015, •006, and .001 respec-
tively. A chi-square transformation was used to combine 
the probabilities and an overall probab.ility of less than 
.001 was obtained. 
Inspection of the data revealed that the interaction 
was such that the higher dosage levels of chlorpromazine 
resulted in greater and more prolonged impairment of dis-
junctive reaction time. 
62. G.W. Snedecor. Statistical methods. Ames, Iowa: 
The Iowa State College Press, 1956. 
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c. Tests of Assumptions 
The assumption that placebos were a control for extran-
eous psychological factors in the experiment :was tested by 
comparing placebo means and no-drug means for all twelve 
groups of observations. Duncan's test for significant gaps 
between the means was used. 63 Only one of the twelve gaps 
was significant. On this basis the assumption that placebos 
serve as adequate controls for suggestion is tenable. A 
summary of the statistical analysis is presented in Table XX, 
Appendix E. 
The assumption of constant conscious motivation :was 
partially tested by comparing the mean reaction times under 
single and double reward conditions. These comparisons 
yielded ••t" scores of 0.47 and 0.18 for subjects A and B 
respectively. On this basis the assumption of relatively 
constant conscious motivation is tenable. A summary of the 
statistical analysis is presented in Table XXI, Appendix E. 
63. D.B. Duncan. Multiple range and multiple F tests. 
Biometrics, 1955, 11, PP• 1-42. 
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CHAPTER VI 
DISCUSSION OF RESULTS 
The findings in this study established a relationship 
between chlorpromazine and reaction time in which the 
subjects' simple reaction times increased following inges-
tion of the drug. · The increase in reaction time occurred as 
a positive function of increase in dosage reaching the 
maximum in this group of observations at 150 milligrams, 
which was the largest dosage administered. 
For the amounts of chlorpromazine used in this experi-
ment there was a tendency for the peak erfect to occur at 
two to two and one-half hours after ingestion of the drug. 
In general the reaction time decreased after reaching its 
peak. However, it was noted that this tendency occurred 
more frequently at lower dosages. At the higher dosage 
levels, 125 and 150 milligrams, simple reaction time, in 
addition to reaching a higher peak, remained at relatively 
high levels for a longer period of time. 
A. Informal Observations 
The subjects were asked to report on their subjective 
reactions to the drug. The most consistent reaction was 
one or lethargy, ranging from mild drowsiness at low dosage 
levels to overwhelming sleepiness at higher dosage levels. 
Subjects frequently fell asleep at 125 and 150 milligrams 
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and had to be awakened to perform the tasks. Another fre-
quent complaint was difficulty in coordinating their legs 
at high dosage levels. For the most part they did not feel 
confused but some mild disorientation appeared at the 
higher dosage levels. 
Subjects reported some interference in motivation at 
high dosage levels. The following is a typical statement. 
I find it difficult to coordinate my legs 
and I can't seem to focus my eyes. I want to do 
something and try it but I can't seem to get 
going so I say what the hell and give up. 
The author does not feel that conscious motivation 
change was the crucial factor in change in response, since 
doubling the reward produced no change in response. It 
seemed as if the subjects wanted to respond rapidly but 
could not. · 
At high dosage levels subjects were quite accurate in 
judging how well or how poorly they had done. At the lower 
dosage levels, however, they were generally inaccurate, 
frequently overestimating the quality of their' efforts. 
A mild euphoria was generally evident at low dosages, 
perhaps due to decreased anxiety. At higher levels, 
depression was the pre-dominant mood. 
During rest intervals subjects frequently played 
cribbage. Decreased ability to "count the hands" and 
increased difficulty in putting the pegs into the holes 
was noted at high dosages. 
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The use of ascending and randomized dosage orders as 
well as single-blind and double-blind presentations was an 
experimental precaution rather than an investigation of 
these two methods. It was informally noted that one 
subject's performance improved on the second round while 
the other subject's performance was somewhat poorer in the 
second series. 
B. Significance of the Results 
The technique of utilizing a response which is quanti-
fiable and can be measured precisely inevaluating the 
effectiveness of a drug is supported by this study. The 
ability to measure reaction time in small units permitted the 
observation of relatively small changes in the response at 
the lower dosage levels. These changes in response would 
probably have been obscured in a more complex response. The 
increase in impairment of the response with increases in 
dosage level, while not an exact linear function, serves to 
underline ,the delaying effect of chlorpromazine on reaction 
time. 
Since reaction time plays a large role in many types of 
behavior, individuals would have to make many adjustments, 
albeit perhaps not conscious ones, when under the influence 
of the drug. In this connection the ability of the subjects 
to retain awareness of how well or how poorly they are 
doing suggests that in adjusting to changes in behavior as a 
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result of chlorpromazine the individual has more resources 
available than is the case with some other drugs. In this 
respect chlorpromazine differs from narcotics and intoxi-
cants with which the individuals' judgment is usually impaired. 
The importance of taking a number of measurements across 
an interval of time is clearly demonstrated in this study. 
Had the responses all been taken at one hour after the drug 
had been administered a large part of the impairment would 
have been missed. Conversely, if all the readings had been 
taken three and one-half hours after drug administration 
impairment of reaction time under low dosages of chlorpro-
mazine would not have been observed. The finding that peak 
effect of the drug occurs at from two to two and one-half 
hours after administration of the drug concurs with a study 
by Bower, Altshule and Cook, reported above. In that study 
the authors found that maximum blockage of a condition 
response occurred two and one-half hours after subcutaneous 
injection of chlorpromazine. 
At dosage levels of 100 milligrams and lower, impair-
ment of simple reaction time occurred with considerably more 
frequency than impairment of disjunctive reaction time. In 
this respect impairment was defined as an increase of ten 
per cent or more in the mean post-drug reaction time from its 
pre-drug level. This finding suggests that the drug has a 
differential effect on motoric and sensory functioning. This 
experiment does not provide a definitive test of the drug's 
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iilf'luence · upon sensory functioning. A direction for future 
research is suggested, however, and some methods of investi-
gation are suggested in Chapter ill .. ~ 
The results obtained in this study are similar to 
findings of impaired motoric behavior in .animals reported by 
Courvoisier and Cook et al. They are also consistent with the 
findings of Karnetsky, Humphreys and Ewarts, reported above • . 
In their study, as in this one, normal subjects were used 
and motoric behavior was impaired. The contrast between the 
results of this study and Shatin's findings of improved 
performance with schizophrenic patients under chlorpromazine 
cannot be easily clarified. In retrospect it appears that 
questions of differential effects of chlorpromazine on 
different groups of subjects could have been answered in this 
study by inclusion of two chronic schizophrenics. This 
remains an area for meaningful research. 
c. Theoretical Considerations 
The effect of chlorpromazine hydrochloride on motoric 
behavior, as represented by reaction time, is impairment of 
the response. The response becomes progressively slower as 
the amount of chlorpromazine increases. Impairment of 
reaction time, both simple and disjunctive, is most evident 
when the dosage reaches 150 milligrams. Because this dosage 
had such a profound effect on the subjects higher dosages 
were not administered. It seems reasonable to assume that 
had the dosage been increased further, impairment of reaction 
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time would have continued to increase until a point was 
reached at which the subjects would have been unable to 
respond. 
Speculations about the reasons for interference with the 
response are hazardous both because of the small sample of 
subjects and because it involves moving into an area in which 
no direct measurements were taken, the central nervous system. 
With these limitations in mind the author will hazard a brief 
theoretical explanation. 
On a behavioral level reaction time is a relatively 
simple sequence of events. In response to a clear auditory 
stimulus ·the subject is r .equired to lift his hand from its 
resting place and move it a short distance to a telegraph key, 
which he is required to press. The entire sequence of events 
required, in the case of this apparatus, between .25 and .30 
seconds. Under normal conditions the response did not appear 
to be either difficult or fatiguing. 
On a neurological level, however, reaction time is a 
more complex response in that, to some extent, the entire 
nervous system is involved, in addition to the musculature 
and the receptor organs. Interference with functioning in 
any of these areas would ultimately produce interferenc-e in 
reaction time. No research on the effect of chlorpromazine 
on receptor organs was found. There was no directly 
comparable research on the effect of the drug on sensory 
input. Karnetsky, Humphreys and Ewarts, in the study 
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reported above, found no interference in sensory or intellec-
tual functioning at low dosage levels of chlorpromazine. 
Many clinical studies of the effect of the drug have noted 
either no change or improvement in sensory and intellectual 
functioning as a consequence of administration of chlorpro- -
mazine. No direct neurological evidence was found regarding 
the effect of the drug on cortical areas primarily involved 
with sensory functioning. 
Neurological research on the effect of chlorpromazine 
on certain areas of the central nervous system which are 
involved in motoric behavior have been discussed in Chapter 
II and are reviewed briefly here. 
Dagsupta and Werner found that chlorpromazine inhibited 
the effect of electrical stimulation in the cortex which, 
prior to drug administration; produced motor activity. 
Grenell, Mendelsson and Elroy, who performed necroscopical 
examination of animals that had received chlorpromazine, 
found the drug to be most highly concentrated in the hypo-
thalamus and reticular formation and to a lesser extent in 
the medulla and cerebral cortex. 
Regarding the musculature, chlorpromazine has been 
observed to interfere with the utilization of adenosine 
tripho-sphoric acid, a coenzyme involved in the breakdown of 
ghycogen in muscle metabolism. Interference with trans-
mission of impulses along motor pathways or with muscle 
contraction would be sufficient to produce a decrement in 
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reaction time. 
The studies discussed above, as well as the results of 
this study, suggest that interference in the motoric part of 
the response is more likely than interference in the sensory 
part of the sequence. The finding that the effect of low 
dosages of chlorpromazine on simple reaction time appears to 
be greater than the effect on disjunctive reaction time 
suggests that .low dosages of chlorpromazine are concentrated 
in areas of the nervous system primarily involved in motoric 
functioning. As the dosage level increases the effect of the 
drug spreads into other areas until, at the higher dosages 
used in this study, interference with a more complex ~esponse 
also becomes evident. Further research in. the fields of 
learning, perception and physiological psychology could 
clarify this problem. 
An interpretation of the prolonged effect of chlorpro-
mazine at higher dosage levels is beyond the competence of 
the author. Conceivably the prolonged effect may be a joint 
function of a fixed rate of absorption and elimination such 
that the higher dosages tend to accumulate and delay 
recovery of function. At the lower dosage levels recovery 
of function is demonstrated by the tendency for reaction 
time to approximate its pre-drug value after three and one-
half hours. 
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D. Suggestions for Further Research 
Areas for future research include investigation of nhe 
effects of chlorpromazine on sensory functioning, learning, 
perception and complex motoric behavior. In addition studies 
on cumulative effects of the drug; and on habituation to .. the 
drug would clarify the finding of prolonged impairment at 
higher dosage levels. A comparison of drug effects in the 
different nosological groups would answer questions raised 
bY conflicting reports regarding the effect of chlorpromazine 
on schizophrenic subjects. 
A direct test of the effect of chlorpromazine on sensory 
functioning co~ld be made in the following manner. Nonsense 
syllables could be presented to subjects under varying 
amounts of chlorpromazine. The stimuli would be presented 
at threshold. At a later time subjects would be retested 
under normal conditions and ·their ability to use the material 
presented could be evaluated. Repeated m~asurements on the 
same would control for intellectual and motivational factors. 
A further control for motivation would be provided by basing 
reinforcement on the quality of performance. 
A direct test of the ·effects of chlorpromazine on 
perception could be achieved by using standard psychophysical 
procedures to establish auditory and visual thresholds under 
· various dosages of chlorpromazine. 
An economical evaluation of effects of the drug on 
different aspects of behavior could be achieved by comparing 
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the performances of the same individual on reaction time, 
learning of nonsense syllables, arithmetical reasoning and 
a sensory threshold task. Results on these tasks could be 
compared indirectly using a Chi-Square analysis of the 
percentage change from pre-drug to post-drug conditions. 
There is some suggestion in the literature that chlor-
promazine effects normals and schizophrenics somewhat 
differently. However, no direct comparisons of the same 
response in normals and schizophrenics was found in the 
literature. A study of the effects of chlorpromazine on 
reaction time in schizophrenics would shed light on this 
problem. Since the drug is known to result in general 
improvement in schizophrenic patients, a similar finding of 
improved reaction time in schizophrenics would not be sur-
prising. 
Studies of cumulative effects of the drug could be 
accomplished by administering the drug at four hour intervals 
and allowing only twenty-four hours rather than forty-eight 
hours between experimental days. The behavioral measures 
would have to be stable and relatively unsuseeptible to 
learning. 
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CHAPTER VII 
SUMMARY AND CONCLUSIONS 
This study was an exploratory study of the influence 
of' chlorpromazine hydrochloride on simple and disjunctive 
reaction time. The author's interest was stimulated by 
his observations on schizophrenics who were under massive 
dosages of the drug . This aroused the author's curiosity 
regarding the effect of chlorpromazine on normal subjects. 
A review of the literature revealed numerous clinical 
and experimental studies indicating impairment of gross 
motor responses and blocking of conditioned reflexes 
involving motor responses. A number of neurological 
studies found increased concentration of the drug in central 
nervous system areas involved in transmission of impulses 
along the pyramidal and extra-pyramidal tracts. Inter-
ferences in sympathetico-adrenal functioning was also noted. 
There were conflicting results reported concerning the 
effect of chlorpromazine on simple intellectual and motoric 
tasks. No intensive investigation of the interrelationships 
between dosage level and motoric behavior in normal individ-
uals was found. 
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Personal observations concurred with published reports 
that a major effect of chlorpromazine was on psychomotor 
functioning. Reaction time was chosen as the psychomotor 
task partly because other investigations indicated that the 
response was relatively consistent throughout the normal 
population within the various age groups. It was therefore 
expected that an experimentally established relationship 
between chlorpromazine and reaction time would obtain through-
out the normal population with such individual differences 
as are found in similar psychophysiological studies. 
The following hypotheses were formulated: 
Hypothesis I. Following the ingestion of chlorpro-
mazine, time required to perform a simple motor 
task will be increased. 
Corollary A. Simple reaction time will increase 
following ingestion of chlorpromazine. 
Corollary B. The increase in simple reaction 
time will vary directly with the amount of 
dosage. 
Hypothesis · II. Disjunctive reaction time will be less 
affected than simple reaction time _by ingestion 
of chlorpromazine. 
Corollary A. Disjunctive reaction time will be 
unaffected by low dosage levels of chlorpro-
mazine. 
Corollary B. Significant impairment of disjunc-
tive reaction time will occur at a higher 
dosage level than the dosage required for 
significant increase in simple reaction time 
(Critical Dosage). 
Corollary .C. At the higher dosage levels, disjunc-
tive reaction time will increase as a 
positive function of dosage. 
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Two adult normal male subjects were selected from a 
group of volunteers among the employees at Boston State 
Hospital. They were screened independently by psychological 
tests and psychiatric interview in order to eliminate the 
variable of psychiatric illness. They were paid ~~1.00 an 
hour. Standard reaction time apparatus which permitted 
measurement in units of ~1 seconds was used. A bell and a 
buzzer were signals for the response of pressing a telegraph 
key. 
The subjects reported at 5:00 P.M. every other day. On 
the first day of testing they familiarized themselves with 
the apparatus. A sufficient number of practice trials were 
administered for the subjects to achieve a stable response. 
Following this day of practice the experiment proper began. 
On the first day of the actual experiment, the subjects 
were tested as soon as they reported. They were required to 
perform ten simple reaction time responses with their left 
hand, ten simple reaction time responses with their right 
hand and ten disjunctive reaction time responses. The total 
of thirty reaction time responses was considered one testing 
period. There were seven such testing periods at regular 
intervals on each day of the experiment. After they 
completed the first testing period they were given three 
identical appearing capsules, all of which contained place-
bos. They were then permitted to eat. One hour after the 
capsules had been administered the second testing period of 
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the day began. The same procedure was followed except that 
the order of performance of the three tasks was changed to 
control for any systematic interference by fatigue or prac-
tice. Following this testing period the subjects rested for 
25 minutes. One and one-half hours after administration of 
the capsules the third testing pe.riod began. At each 
succeeding half hour another testing period occurred until, 
at three and one-half hours after administration of the 
capsules, the last testing period of the day took place. 
This made a total of seven testing periods, one of which 
occurred prior to administration of the capsules and six of 
which occurred following administration of 'the capsules. On 
each day of testing there were twenty simple and ten disjunc-
tive reaction time responses prior to drug administration 
and 120 simple and 60 disjunctive reaction time .responses 
taken after drug administration. Following the last testing 
period of the day, the subjects were dismissed and asked to 
return in two days at the same time. 
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On the second day of the experiment the same procedure 
was followed except that the three identical appearing 
capsules contained a total of 25 milligrams of chlorpromazine. 
On each succeeding experimental day the dosage of chlorpro-
mazine was increased by 25 milligrams until the dosage of 
150 milligrams was reached on the seventh day of testing. 
These se~en experimental days constituted the first part of 
the experiment and was referred to as the single-blind series. 
Following the single-9lind series the subjects were tested 
without drug under the same procedure outlined above. 
The second part of the study was a replication of the 
first except that this time the order of dosage presentation 
was randomized and neither subjects nor experimenter knew 
the contents of the three capsules which were administered 
on each experimental day. Eight experimental days consti-
tuted the second part of the experiment and this second series 
was called the double-blind series. The purpose of concealing 
the contents of the drug from the subjects (single-blind) and 
both the subjects and the experimenter (double-blind ) was to 
prevent the interference of suggestion in the response 
process. This precaution was felt to be necessary even though 
the measurements were objective and the subjects had no way 
of knowing how well or how poorly they were doing. 
Following the double-blind series the subjects were 
tested for three more days. This time they were offered 
double pay if they could improve their performance by ten 
per cent. A placebo, 75 milligrams and 150 milligrams were 
used as the dosages. This series was called the double-
reward series. Results were compared statistically to pro-
vide a partial test of the assumption of constant conscious 
motivation. 
During the 25 minute rest period the subjects' behavior 
was not controlled except that they were denied drugs or 
stimulants, including tea and coffee. For the most part 
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they occupied themselves playing cribbage, reading and, at 
the higher dosage levels, sleeping. They were advised 
against using alcohol during the duration of the experiment 
because of the known potentiating effects of chlorpromazine 
on central nervous system depressants. They were encouraged 
to get a good night's sleep, avoid dri~ing on evenings they 
had taken the drug and to report any time they had taken 
any other drug. They were followed closely medically. As 
far as the experimenter knows the subjects conformed 
remarkably well to the requests made of them. 
The interval between the ready signal and presentation 
of the stimulus varied between 1 and 5 seconds to avoid 
temporal conditioning. The dummy switch was used to dis-
courage anticipatory responses. A copy of the instructions 
given to the subjects may be found in Appendix A. 
Analysis of variance was used to evaluate the signifi-
cance of the effects of amount of dosage, time after drug 
administration and the effects of the interaction of dosage 
level and time after drug administration on simple and complex 
reaction time. The results were in the expected direction. 
Variances contributed by dosage, time and interaction were 
all significant at a level of less than .001. 
The effect of chlorpromazine was to increase simple 
reaction time. The increase in simple reaction time was 
observed with all dosages of chlorpromazine. Simple reaction 
time became slower as the dosage of chlorpromazine was 
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increased. The maximum impairment occurred under 150 milli-
grams which was the largest dosage used in this study. 
Disjunctive reaction time was also increased under 
chlorpromazine. The increase from pre-drug to post-drug 
mean reaction time was smaller for disjunctive reaction 
time than for simple reaction time at the lower dosage levels. 
At dosages of 100 to 150 milligrams impairment of disjunctive 
reaction time was considerable. 
The impairment of reaction time by chlorpromazine 
tended to be greatest between two and two and one-half hours 
after the drug was administered. There were a few exceptions. 
At the lower dosages reaction time tended to return to its 
pre-drug level by three and one-half hours after drug adminis-
tration. However, at the higher dosages the impairment of 
both simple and disjunctive reaction time remained sub-
stantially above its pre-drug level. Thus higher dosages 
produced greater and prolonged impairment. 
A comparison of reaction time under placebo and without 
drug revealed no differences between the means. This finding 
supported the assumption that placebos served as adequate 
controls for suggestion. Offering the subjects double 
reward for improved performance resulted in no improvement 
in the mean reaction times of the subjects. This finding 
supported the assumption of relatively constant conscious 
motivation!~' 
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The experimental results establish a relationship 
between chlorpromazine and fine motor behavior as repre-
sented by reaction time. Some theoretical considerations 
and suggestions for future research are included in Chap-
ter VI. 
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APPENDIX A 
INSTRUCTIONS TO SUBJECTS 
INSTRUCTio-NS · TO SUBJECTS 
The following instructions were given to the subjects 
before each series of trials. 
"You are to place your hands on the knobs in front of 
you. When you he ar the bell or buzzer press down the appro-
priate telegraph key as fast as you can. Use your left hand 
to respond to the bell and your right hand to respond to the 
buzzer. Keep the key depressed until I say •o.K.•. 
"Before each set of trials I will tell you whether the 
stimulus will be the bell, the buzzer or either one. Before 
each trial I will say •ready' before I start the bell or 
buzzer. Do not move your hand before you hear the bell or 
buzzer. If you do we will have to repeat the series." 
Following this presentation the subject was told which 
task was first, i.e., bell, buzzer or either one. The 
experimenter then said "ready" and at an interval of from 
1 to 5 seconds· followed this comment by pressing a toggle 
switch starting the stimulus and the chronoscope. The 
stimulus remained on until the subject depressed the key 
which shutoff both the stimulus and the chronoscope. The 
experimenter then read the time, returned the chronoscope 
to zero position and started the procedure again. 
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APPENDIX B 
COiviPARIS ON OF LEFT AND RIGHT HAND Sif.'IPLE REACTION •rn:IE 
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APP 1--1DIX 0 
R"'<'A.CTION TI .... 
TABLE VIII 
.N _-_LYSIS OF Vi':RI Al'WE, . 'FT T-Jr'ND S TYTPLE RF. CTI N 
'pn~ , SINGLE BLIND SERI ""S , SUBJECT' A 
Sourc e of 
Ve..ri ence 
DOSP e 
-
Time 
InterP.ctj_on 
::teDlic!?tions'~~· 
Residua l 
Tot21 
Sum of 
SquB r es 
283 5 
1269 
4149 
380 
10331 
18964 
d . f . 
7 
6 
42 
9 
495 
---------- --·-- -
Mean 
Squ are s 
405 
211 -1 
98 
4 2 
20 
F 
20 -25 
1 0 -58 
lj . • 9 
2 .1 
-
Pis less 
then 
o.ool 
o . oo1 
0 . 005 
·Ns 
---
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~· Extr8.ction of thi s v a ri Pnce was a me then1a tic - l rather th2n en 
e xDer i ment .1 l)r o cedure. It r enrePent s the v ari Pn ce c ontr b ted 
y t- k i ne ten 'l"_~esuremen t s 8t e e.ch testing period. I ts a.dd i tion 
to the re f' id,,~, - v eri ence w-ould make no appreci a.b le differen ce in 
the F r a tion . 
TABLE IX 
ANALYSIS OF VARIANCE, RIGHT HAND SIMPLE REACTION TIME, 
SINGLE BLIND SERIES , SUBJECT A 
------- - ----------
Source Sum of Mean p is 
of Squares d .f. Squa.re F less 
Variance th.sn 
. --- - -- ----. ...... - --- --- -----
D sac;e 3580 7 511.4 '22.9 o.oo 
T me 2660 6 445 19.9 0 .()() 
I tera tion 4446 42 103 . 9 4.74 0 .005 
Renlic a.t 0 s 360 0 40 1.79 NS 
./ 
Resid e l 11026 4 0 .... ,...,:) 22.3 
To ta l '22072 559 
- ---- - -- -----
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TABLE X 
-~NALYSIS OF VARI.Al'>J CE; LEF'r HAND SIMPLE REACTION 
Source of 
Veri a .. nce 
TH1E, DOUBLE BLIND SERI •.S, SUBJECT A 
Sum of 
qua.res 
eL f. Mean 
Square 
F P is less 
than 
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TABLE XI 
AN/IT_YS IS OF V ARLlll~ CE, RIGHT HAN D SIMPLE REACTION 
TIME, DOUBLE BLI ND SERI ES, SUBJEC T A 
Source of Sum of d .f. Me an F 
VBri"nce Squa r es s 
-
uar e 
Dose 2' e 9424 7 332 30 .4 
Tim 4?02 6 ·700 15·9 
InterPcti on 6702 42 159 •6 3 -6 
Renllc c- tions 378 9 42 . 96 
ResiduPl 2 699 495 43 .83 
ToteJ 38311 
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F is less 
than 
---
0 .001 
o .oo1 
0 . 005 
NS 
TABLE XI I 
ANALYSIS -oF VARIM~CE, LEFT H ft~D SIMPLE REACTION 
TIME, SINGLE BLIND SERIES, SUBJEC T B 
Sov.rce of 
Veri an ce 
OSF!ge 
T :m9 
InterPction 
Reul:i.. c <? ti ns 
Residu.e J. 
Tota l 
Sum of 
Squares 
15753 
4626 
8990. 
205 
7427 
37001 
d.r. 
7 
6 
42 
a 
./ 
495 
Mean 
Square 
2250.4 
771 
214 
22. 7 
15-0 
F 
150 
51.4 
14 . 2 
1.51 
P is less 
than 
o.oo1 
0.001 
0.001 
NS 
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TABLE XIII 
ANALYSIS OF VARI Al~ CE, RI GHT H.Ai"J D S I MPLE REACTI ON 
TIME, S I NGLE BLIND SERI ES , SUBJECT B 
Sourc e of 
V ari~:mc e 
Sum of 
Squa r es 
d . f '. Mea n 
SquAre 
F P is l ess 
t h an 
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TABLE XIV 
ANALYSIS OF V ft.RI :~]:\: CS, LEFT HI\.N D SI MPLE RE t,CTION 
TIMZ, DCUBLE BLI ND SE~IES, sr~JECT B 
Source of 
V8rj_en ce 
Do SPf e 
Time 
Interaction 
Repl c E>t ions 
Re s ic u2 1 
Tot a.l 
Sum of 
Squares 
7491 
919 
3533 
180 
6164 
18287 
d . f . 
7 
6 
42 
9 
495 
559 
Mean 
Sguare 
1070 
1 53 
84 .1 
20 
12 . 45 
F 
85 - 9 
12 . 3 
6.75 
1 . 6 
P is less 
than 
0 . 001 
0 . 001 
0 . 001 
NS 
8 
TABLE XV 
ANALYSIS OF VARIAN CE, RIGHT HM~D SIMPLE REACTION 
TIME, DOUBLE BLIND SERIES . SUBJECT B 
Source of 
VP.r ~ ance 
DosEl.f.: e 
Time 
Interaction 
Replications 
Re i clt1B l 
Total 
Su .. rn of 
Squares 
2835 
1269 
4149 
380 
10331 
18964 
d . f . 
7 .. 
6 ~ 
42 
9 
495 
559 
Mean 
Square 
929 
85 
159 -4 
32 -5 
5 -54 
F 
167 . 68 
11).34 
28 . 7 
5 -86 
P is less 
than 
0 . 001 
0.001 
0.001 
0.01 
" "PEN DI T) 
q• r T vs 1S 02 VARI AN CE' DnLrr mr: 'T'TV;.: PE.AC TI 1\[ 'T'JTVT"t<.: 
Source of 
TABLE XVI 
ANALYSIS OF VARIANCE, DISJUNCTIVE REACTION TIME 
SINGLE BLIND SERIES. SUBJECT A 
----- -·--
Sum of d .f. Mean F p 
90 
is less 
Variance Squares Sq1..1ere than 
~-----------------~ 
Dosaee 3687 7 526.71 5 · 92 0.001 
Time 858 6 143 1 . 6,0 o. 5 
Int srB.ction 4942 42 117.66 1.32 0.10 
Re-o1 cP tions 873 9 97 1.09 NS 
Res idu.Al 44016 495 88 .2 
Tot 54376 559 
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TABLE TVII 
.ANA YSIS OF VARI ANCE , DISJUNC TI VE R-'ACTION TH1E 
DOUBLE BLIND SERIES . SUBJECT A 
Source of 
Vc:.,.. i ance 
DoRafe 
T me 
nt<?re ction 
Replicetions 
Residuel 
Total 
Sum of 
Squares 
8085 
990 
3854 
661 
20953 
34543 
d . f . 
7 
6 
42 
9 
495 
559 
Mean 
Squa.re 
1155 
165 
91 .76 
73 .44 
42 .32 
F 
27 . 2 
3 . 89 
2 . 16 
1.73 
P -· s less 
th n 
0.001 
0 .0015 
0 . 0015 
s 
92 
TABLE XVIII 
A1JALYSIS OF VARIAN CE, DISJUNCTIVE REACTION TIME 
SINGLE BLIND SERIES . SUBJECT B 
----
Source of Sum of d . f . Mean F F s l ess 
Variance Sq ares Squ re than 
--- ----
OSFl.P'I-3 19190 7 2741 45 . 1 0 . 001 
Time 3371 6 561 . 8 9 · 2 0 . 001 
Interact " on 50 4 1+2 119 · 3 1 . 9 0 . 006 
Renl "cPt i ons 1130 9 125 -5 2 . 0 o.os 
Res _ue 1 30088 495 60 . 7 
Total 58793 559 
-------- --- --
TABLE XIX 
ANALYSIS OF VARIANCE , DISJ'UNCTIVE REACTION TIME 
DOUBLE BLIND SERIES . SUBJECT B 
---- -·--
So rce of Sum of d .f. Mean F 
Varlance Squares Square 
-----· 
Dosa.ge 12898 7 1842 36 .3 
Tirr1e 317 6 52 . 8 1 . 04 
I nter ction 461+3 42 110. 5 2 .18 
Replicat ions 707 9 78 . 5 1 . 54 
ResiclJal 25118 495 50 . 7 
Total 1.~3683 559 
I' s less 
than 
0.001 
0.35 
0 . 001 
NS 
T:!£S'T'c 0F · SSl:Jl'!PTI O S 
94 
T t :::::r . v v 
0 n1·T 1 F IWYi\T OF Tv•EA 1': .C TI01J TH1E, 'lli THOTJT· DRUGS .AN 
UNDER FLACli: (' S 
.Subjr:-ct Task No Drt Pl a ebo Gap LeFst p 
Mea n(log ) Mea.n (log ) S:l n 
lccmt 
Ge<n. 
----
A SRT 148 . 8 146.~ '2-30 -,.go rs 
f, SRT 143-3 149 . 3 6 .00 4 . 45 0-0 5 _..., 
'? SftT 152 .1 .151- 3 0.80 3 -41 NS 
:3 S '=tT 151-2 151 -9 0.70 3 .10 NS 
' 
c• T 144 . 8 144 . 8 o .oo 4 .13 NS r- ,_, 
\ S~ T 143.0 147 -7 4 . 70 5 -79 NS .n 
'"' 3RT J 49 .3 150 . 4 .10 ~ .?3 NS _} 
·-· SRT 150.1 151 . 9 1 . 60 2 • lt-4- NS 
J~ DRT 158.4 166 . 5 8 . 20 8 . 34 NS 
.r DRT 161 .6 64 . 3 2 -70 5 . 68 NS 
B DRT 169 . 9 173 ·0 ) .10 6 . 84 NS 
J3 DRT 169 . 6 168 . 6 1.00 6 .09 NS 
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TABLE XXI 
COMPP.RISON OF SIMPLE REACTION TIME UNDER SINGLE AND 
DOUBLE RE\vARD CONDIT I ONS 
Nlean Simnle J\.1ean Sirrrple t p 
Reaction Time Ree.ction Time 
Single Reward Doubl Revrard 
( . 01 sec on s) ( . 01 seconds) 
·-··-·- - - -- - --- -- ---~--
A 3 . 1 29 -7 0.47 rr 
B ?4 . 6 31+ . 1 0.18 l s 
------------------------
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100. 
DISSERTATION ABSTRACT 
This study aimed to clarify some relationships between 
the drug chlorpromazine hydrochloride and reaction time. 
Chlorpromazine is a drug in widespread use in the treatment 
of mental illnesses, particularly schizophrenia. The 
mechanisms of its action are not clearly defined physically 
or psychologically. The author~ curiosity in the drug was 
stimulated by observations of its effects in a hospital 
setting . This stimulated curiosity in the effects of the 
drug on normal subjects. 
Major interest in the drug has centered about its 
effect in contributing to remissions in schizophrenia. Many 
authors have described "dramatic" improvements soon after 
introduction of the drug, ranging from amelioration of 
symptoms to a "cure" for the illness. A frequently reported 
observation was diminution in assaultiveness, hyperactivity 
and destructiveness. A number of studies reported inhibi-
tion of conditioned responses in animals. Neurologists 
found increased concentration of the drug in areas of the 
central nervous system involved in motor functioning. 
Some studies report the effects of rather large 
dosages of chlorpromazine on some simple intellectual and 
motoric tasks, but the results were contradictory. 
In the absence of known basic studies it was decided 
that the most fruitful area for investigation was the 
effect of chlorpromazine on psychomotor functioning. 
Reaction time was chosen as an experimental variable, partly 
because it lends itself to precise measurement and partly 
because it has been demonstrated to be relatively consistent, 
within individual age groups, throughout the normal popula-
tion. In addition reaction time is an integral part of all 
responses. Working with normal subjects and established 
psychophysical procedures some basic information was 
gathered. 
The general hypothesis was that under the influence 
of chlorpromazine reaction time would increase and that 
increase in reaction time would vary directly with amount 
of dosage. It was expected that low dosage levels of 
chlorpromazine would have less effect on disjunctive reac-
tion time than on simple reaction time. 
The method of investigation chosen involved repeated 
measurements on the same s~bject. Two normal adult males 
served as subjects. A standard reaction time apparatus 
which permitted measurements in units of .01 seconds was 
used. The stimuli were a bell and a buzzer; and response 
2. 
involved pressing a telegraph key. Controls for fatigue, 
set, temporal conditioning,practice and suggestion were 
introduced. The latter was controlled by placebos and by 
utilizing both single-blind and double-blind dosage series. 
Subjects were tested on two different days with each 
dosage used. The dosages were o, placebo, and 25, 50, 75, 
100, 125 and 150 milligrams. There were three tasks: 
simple reaction time, left hand; simple reaction time, right 
hand; and disjunctive reaction time. On each day reaction 
times were taken prior to drug administration and at 1, 1!, 
2, 2!, 3 and 3! hours after drug administration. A total 
of 3600 reaction times were taken for each subject. 
The data were treated statistically by analysis of 
variance. Separate analyses of variance were computed for 
each experimental condition and each subject. The data 
were converted to logarithms to correct a mild positive 
skewness. 
The effect of chlorpromazine was to increase reaction 
time. The increase occurred as a positive non-linear 
function of dosage, reaching its maximum in this study at 
150 milligrams. The percent change in reaction time from 
pre-drug to post-drug measures was greater for simple 
reaction time than for disjunctive reaction time at dosages 
of 100 milligrams and less. At 125 and 150 milligrams both 
types of reaction time appeared to be equally impaired. 
In general, peak effects were reached between two and 
two and one-half hours after drug administration. At lower 
dosage levels reaction time tended to return to its pre-
drug levels after three and one-half hours, at which time 
the last readi ng was taken. At the higher dosage levels 
impairment in reaction time was greater and at three and 
one-half hours remained substantially above its pre-drug 
level. 
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